4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-07-040680
CIK 0001009356operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:23 PM ET
Size
11.4 KB
Accession
0001209191-07-040680
Insider Transaction Report
Form 4
HARRAL WILLIAM III
Director
Transactions
- Award
Common Stock
2007-07-01+9,230→ 37,704 total
Holdings
- 2,953
Option to Buy Common Stock
Exercise: $12.15From: 2005-09-30Exp: 2015-06-08→ Common Stock (2,953 underlying) - 20,000
Option to Buy Common Stock
Exercise: $20.89Exp: 2015-09-30→ Common Stock (20,000 underlying) - 1,564
Option to Buy Common Stock
Exercise: $22.57From: 2005-09-30Exp: 2014-08-23→ Common Stock (1,564 underlying) - 6,254
Option to Buy Common Stock
Exercise: $12.15From: 2005-09-30Exp: 2015-06-08→ Common Stock (6,254 underlying) - 4,343
Option to Buy Common Stock
Exercise: $24.24From: 2005-09-30Exp: 2014-07-14→ Common Stock (4,343 underlying)
Footnotes (2)
- [F1]Represents restricted stock award which will vest in its entirety on July 1, 2008, subject to continued service on the Board of Directors.
- [F2]Option vests at a rate of 1/36th per month, with a vesting commencement date of October 1, 2005.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:23 PM ET
- Size
- 11.4 KB